EnteroMedics Inc·4

Feb 10, 4:50 PM ET

EnteroMedics Inc 4

4 · EnteroMedics Inc · Filed Feb 10, 2017

Insider Transaction Report

Form 4
Period: 2017-02-08
Transactions
  • Award

    Director Option (Right to Buy)

    2017-02-08+30,00030,000 total
    Exercise: $7.12From: 2017-02-08Exp: 2027-02-08Common Stock (30,000 underlying)
Holdings
  • Common Stock

    0
  • Director Option (Right to Buy)

    Exercise: $325.50Exp: 2025-07-31Common Stock (23 underlying)
    23
  • Director Option (Right to Buy)

    Exercise: $52.50From: 2016-05-04Exp: 2026-05-04Common Stock (42 underlying)
    42
Footnotes (3)
  • [F1]On December 27, 2016, EnteroMedics Inc. effected a 1-for-70 reverse stock split of its issued and outstanding shares of common stock, par value $0.01 per share, resulting in a proportional decrease in the total shares of common stock beneficially owned by the reporting person. all previously reported exercise prices, option grants and similar instruments convertible into common stock were proportionally adjusted to reflect the reverse split.
  • [F2]25% of the shares subject to the option are exercisable immediately. The remaining 75% of the shares subject to the option shall vest in a series of thirty-six (36) successive equal monthly installments upon completion of each month beginning on August 31, 2015 and ending on July 31, 2018.
  • [F3]Vests immediately as to 25% on date noted and thereafter in cumulative installments of 1/36th per month.

Documents

2 files
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION

  • EX-24.4_700809

    POA DOCUMENT